AbbVie Inc. (ABBV) vs Intel Corporation (INTC)
See how AbbVie Inc. and Intel Corporation differ across market data and performance, so you can decide which asset best fits your strategy.
$256.42
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page$89.51
NasdaqGS
Intel Corp is a major semiconductor company that designs and manufactures microprocessors for the worldwide PC and data center markets. The company helped establish the x86 microprocessor architecture and played a central role in advancing Moore’s law through semiconductor manufacturing innovation. Intel continues to hold leading market share in central processing units for both personal computers and servers. The company is working to revitalize its chip manufacturing operations through Intel Foundry while developing advanced products within its Intel Products segment.
View Full PageKey Metrics Comparison
AbbVie Inc.ABBV
Market Cap$453.124B
Price$256.42
24h Change+0.37%
24h Volume$4.24M
Employees57,000
Shares Outstanding1,768,169,012
Intel CorporationINTC
Market Cap$473.159B
Price$89.51
24h Change+0.04%
24h Volume$64.52M
Employees85,100
Shares Outstanding5,026,000,000
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
ABBV
48.9%INTC
51.1%Volume Share
Share of combined 24h volume
ABBV
6.2%INTC
93.8%24h Performance
Price change over last 24 hours
ABBV
0.37%INTC
0.04%Price Comparison
AbbVie Inc.
Intel Corporation